Alexandria Real Estate Equities (ARE) remains a Buy, supported by a compelling margin of safety despite headwinds. ARE faces persistent supply-demand imbalances in key life science markets, but recent improvements in venture funding and leasing trends offer cautious optimism. Alexandria is responding defensively — asset sales, a 45% dividend cut, lower G&A, and a pivot to JV capital — as credit downgrades reflect the same headwinds already priced in.
Alexandria Real Estate has declined 75% in five years due to oversupply, higher rates, and a biotech funding slowdown. Despite recent negative rental rate changes and falling occupancy, ARE's best-in-class assets are positioned for a flight to quality as supply dries up. Life sciences market fundamentals are stabilizing, with construction pipelines shrinking and key markets showing early signs of recovery.
Alexandria Real Estate Equities, Inc. (ARE) is deeply undervalued, but technical entry timing is critical for optimal returns. ARE's FFO faces near-term headwinds from major lease expirations in 2027, with recovery expected as new leases and projects ramp up. I target a $45 average entry, buying in tranches on further weakness or a breakout above $55, to balance value and momentum.
| Office REITs Industry | Real Estate Sector | Peter Moglia CEO | XMUN Exchange | US0152711091 ISIN |
| US Country | 514 Employees | 30 Sep 2026 Last Dividend | 24 Apr 2006 Last Split | 27 May 1997 IPO Date |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an esteemed member of the S&P 500, stands as a leader in the mission-driven life science Real Estate Investment Trust (REIT) sector, committed to making a profound and enduring impact on the world. Founded in 1994, Alexandria established the life science real estate niche and has since maintained its position as the foremost and most experienced owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses. These campuses are strategically located in AAA innovation cluster locations across the United States, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. With a substantial market capitalization totaling $33.1 billion and an extensive asset base spanning 73.5 million square feet in North America as of December 31, 2023, Alexandria exemplifies a remarkable track record. This track record includes creating Class A/A+ properties that foster highly dynamic and collaborative environments crucial for attracting and retaining top-tier talent and supporting the success of its innovative tenants. Additionally, through its venture capital platform, Alexandria actively provides strategic capital to groundbreaking companies in life science, agrifoodtech, climate innovation, and technology sectors, further demonstrating its comprehensive commitment to fostering growth and excellence within these critical areas of innovation.
Alexandria excels in developing, owning, and operating collaborative mega campuses in AAA innovation cluster locations. These campuses are tailored for companies in the life sciences, agtech, and advanced technology sectors, offering state-of-the-art facilities that promote productivity, efficiency, creativity, and success.
The company has a proven expertise in creating Class A/A+ properties, which are central to its strategy of clustering such properties within mega campuses. These developments not only meet the highest standards of quality and environmental sustainability but also provide tenants with the necessary infrastructure to thrive and innovate.
Alexandria extends its impact beyond real estate through strategic venture capital investments in transformative companies within the life science, agrifoodtech, climate innovation, and technology sectors. This venture capital platform enables Alexandria to support the growth and development of these sectors by providing critical capital and resources.